中文English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R
Volume 35 Issue 12
Dec.  2019
Turn off MathJax
Article Contents

Liver transplantation for the treatment of intrahepatic cholangiocarcinoma: Controversies and perspectives

DOI: 10.3969/j.issn.1001-5256.2019.12.006
  • Received Date: 2019-11-12
  • Published Date: 2019-12-20
  • Liver transplantation is the only effective method for the treatment of end-stage liver disease,but there are still controversies over its application in the treatment of intrahepatic cholangiocarcinoma( ICC). ICC has a high degree of malignancy,occult symptoms,and a lack of specific clinical manifestations in the early stage. Most patients are in the advanced stage at the time of diagnosis and lose the opportunity for surgical resection,and thus they tend to have poor prognosis. With the research advances in liver transplantation for the treatment of ICC,development of standardized criteria for patient selection and combination with neoadjuvant therapy and adjuvant therapy may become a promising method for the treatment of locally advanced ICC.

     

  • loading
  • [1] GUPTA A,DIXON E. Epidemiology and risk factors:Intrahepatic cholangiocarcinoma[J]. Hepatobiliary Surg Nutr,2017,6(2):101-104.
    [2] SHAIB Y,EL-SERAG HB. The epidemiology of cholangiocarcinoma[J]. Semin Liver Dis,2004,24(2):115-125.
    [3] WEBER SM,RIBERO D,O’REILLY EM,et al. Intrahepatic Cholangiocarcinoma:Expert consensus statement[J]. HPB,2015,17(8):669-680.
    [4] ROBLES R,FIGUERAS J,TURRIN VS,et al. Spanish experience in liver transplantation for hilar and peripheral cholangiocarcinoma[J]. Ann Surg,2004,239(2):265-271.
    [5] SOTIROPOULOS GC,KAISER GM,LANG H,et al. Liver transplantation as a primary indication for intrahepatic cholangiocarcinoma:A single-center experience[J]. Transplant Proc,2008,40(9):3194-3195.
    [6] SAPISOCHIN G,FIDELMAN N,ROBERTS JP,et al. Mixed hepatocellular cholangiocarcinoma and intrahepatic cholangiocarcinoma in patients undergoing transplantation for hepatocellular carcinoma[J]. Liver Transpl,2011,17(8):934-942.
    [7] PANJALA C,NGUYEN JH,AL-HAJJAJ AN,et al. Impact of neoadjuvant chemoradiation on the tumor burden before liver transplantation for unresectable cholangiocarcinoma[J]. Liver Transpl,2012,18(5):594-601.
    [8] RAZUMILAVA N,GORES GJ. Cholangiocarcinoma[J]. Lancet,2014,383(9935):2168-2179.
    [9] BRIDGEWATER J,GALLE PR,KHAN SA,et al. Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma[J]. J Hepatol,2014,60(6):1268-1289.
    [10] SAPISOCHIN G,de LOPE CR,GASTACA M,et al. Intrahepatic cholangiocarcinoma or mixed hepatocellular-cholangiocarcinoma in patients undergoing liver transplantation:A Spanish matched cohort multicenter study[J]. Ann Surg,2014,259(5):944-952.
    [11] SAPISOCHIN G,RODRGUEZ de LOPE C,GASTACA M,et al.“Very early”intrahepatic cholangiocarcinoma in cirrhotic patients:Should liver transplantation be reconsidered in these patients?[J]. Am J Transplant,2014,14(3):660-667.
    [12] SAPISOCHIN G,FACCIUTO M,RUBBIA-BRANDT L,et al.Liver transplantation for"very early"intrahepatic cholangiocarcinoma:International retrospective study supporting a prospective assessment[J]. Hepatology,2016,64(4):1178-1188.
    [13] HONG JC,JONES CM,DUFFY JP,et al. Comparative analysis of resection and liver transplantation for intrahepatic and hilar cholangiocarcinoma:A 24-year experience in a single center[J]. Arch Surg,2011,146:683-689.
    [14] HONG JC,KALDAS FM,KOSITAMONGKOL P,et al. Predictive index for long-term survival after retransplantation of the liver in adult recipients:Analysis of a 26-year experience in a single center[J]. Ann Surg,2011,254(3):444-448; discussion 448-449.
    [15] FACCIUTO ME,SINGH MK,LUBEZKY N,et al. Tumors with intrahepatic bile duct differentiation in cirrhosis:Implications on outcomes after liver transplantation[J]. Transplantation,2015,99(1):151-157.
    [16] NJEI B,SCHILSKY ML,DITAH IC,et al. Should liver transplantation be reconsidered in patients with intrahepatic cholangiocarcinoma? A systematic review and meta-regression analysis of epidemiologic evidence[J]. Gastroenterology,2015,148(4):S-1036.
    [17] GOLDSTEIN RM,STONE M,TILLERY GW,et al. Is liver transplantation indicated for cholangiocarcinoma?[J]. Am J Surg,1993,166(6):768-771; discussion 771-772.
    [18] CARRAFIELLO G,LAGAND,COTTA E,et al. Radiofrequency ablation of intrahepatic cholangiocarcinoma:Preliminary experience[J]. Cardiovasc Intervent Radiol,2010,33(4):835-839.
    [19] TSE RV,HAWKINS M,LOCKWOOD G,et al. Phase I study of individualized stereotactic body radiotherapy for hepatocellular carcinoma and intrahepatic cholangiocarcinoma[J]. J Clin Oncol,2008,26(4):657-664.
    [20] KOPEK N,HOLT MI,HANSEN AT,et al. Stereotactic body radiotherapy for unresectable cholangiocarcinoma[J]. Radiother Oncol,2010,94(1):47-52.
    [21] ZHOU L,DU GS,ZHU ZD,et al. Report on the efficacy of triple therapy in the prevention of recurrence after liver transplantation for advanced intrahepatic cholangiocarcinoma[J/CD].Chin J Oper Proc Gen Surg:Electronic Version,2014,8(1):39-41.(in Chinese)周林,杜国盛,朱志东,等.预防晚期肝内胆管细胞癌肝移植术后复发的三联疗法疗效报道[J/CD].中华普外科手术学杂志:电子版,2014,8(1):39-41.
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Article Metrics

    Article views (1300) PDF downloads(236) Cited by()
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return